Home - Products - Others - Other Targets - 4-O-beta-Glucopyranosyl-cis-coumaric acid

4-O-beta-Glucopyranosyl-cis-coumaric acid

CAS No. 117405-48-8

4-O-beta-Glucopyranosyl-cis-coumaric acid( —— )

Catalog No. M31432 CAS No. 117405-48-8

4-O-beta-Glucopyranosyl-cis-coumaric acid is a natural product.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 601 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-O-beta-Glucopyranosyl-cis-coumaric acid
  • Note
    Research use only, not for human use.
  • Brief Description
    4-O-beta-Glucopyranosyl-cis-coumaric acid is a natural product.
  • Description
    4-O-beta-Glucopyranosyl-cis-coumaric acid is a natural product.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    117405-48-8
  • Formula Weight
    326.29
  • Molecular Formula
    C15H18O8
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Glycyrrhizin-6-dimet...

    Glycyrrhizin-6′′-methylester (compound 22) is a glycyrrhizin that can be isolated from licorice root. Glycyrrhizin-6′′-methylester can participate as an aglycone in the formation of methyl glucuronate, producing a sweet and licorice taste, but no bitterness. This reveals the importance of the free carboxyl group on the glycoside cone-bound glucuronic acid for natural sweetness and licorice taste.

  • Gatipotuzumab

    Gatipotuzumab (PankoMab) is a novel humanized monoclonal antibody conjugated to the tumor-associated epitope of mucin 1 (TA-MUC1) with potential anti-tumor activity for the study of recurrent epithelial ovarian cancer.

  • Isonardosinone

    Isonardosinone shows potential role in the treatment of neuroinflammation conditions, it inhibits NF-?oB- and MAPK-mediated inflammatory pathways.